Literature DB >> 7526148

Gold sodium thiomalate down-regulates intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 expression on vascular endothelial cells.

R Koike1, I Miki, M Otoshi, T Totsuka, H Inoue, H Kase, I Saito, N Miyasaka.   

Abstract

We examined whether antirheumatic drugs alter cytokine- or lipopolysaccharide-induced expression of adhesion molecules on vascular endothelial cells. Human umbilical cord vein endothelial cells were co-cultured with various antirheumatic drugs in the presence of inflammatory cytokines, and adhesion molecule expression was measured by cell enzyme-linked immunosorbent assay and Northern blot analysis. Among these antirheumatic drugs, gold sodium thiomalate significantly inhibited intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 expression on vascular endothelial cells and suppressed cellular binding between human monocytic cell lines, including U937 and HL-60 cells, and interleukin-1 beta-stimulated vascular endothelial cells. It is speculated that down-regulation of adhesion molecules might be one of the novel mechanisms of action of gold sodium thiomalate.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7526148

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  3 in total

Review 1.  Leukocyte-endothelial cell adhesion: avenues for therapeutic intervention.

Authors:  J Panés; M Perry; D N Granger
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

2.  Gold ions bio-released from metallic gold particles reduce inflammation and apoptosis and increase the regenerative responses in focal brain injury.

Authors:  Agnete Larsen; Kristian Kolind; Dan Sonne Pedersen; Peter Doering; Mie Ostergaard Pedersen; Gorm Danscher; Milena Penkowa; Meredin Stoltenberg
Journal:  Histochem Cell Biol       Date:  2008-06-10       Impact factor: 4.304

Review 3.  Adhesion molecules in inflammatory diseases.

Authors:  R González-Amaro; F Díaz-González; F Sánchez-Madrid
Journal:  Drugs       Date:  1998-12       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.